“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  CLX

CLOROX CO /DE/

LISTEDNYSE
SYMBOLCLX
SIC2842
STATE OF INC.DE
FISCAL YEAR ENDSJune 30
CIK21076

SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions024682016201720182019202020212022202320242025RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share0.002.004.006.008.002016201720182019202020212022202320242025EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 6/30/25

($ millions)Amount%
Total debt2,48888.6
Stockholders' equity32111.4
Total capitalization2,809100.0

120,921,351 shares outstanding at 16 April 2026 (cover page of the 10-Q filed 30 April 2026).

LONG-TERM DEBT 6/30/25

($ millions)Amount
Long-term debt, incl. current maturities2,484
Long-term debt, noncurrent2,484
Current maturities0
Short-term borrowings / commercial paper4

CAPITAL STOCK 6/30/25

Common shares authorized750,000,000
Common shares issued130,741,461
Treasury shares8,047,198
Par or stated value per share ($)1
Preferred stock ($ millions)0
Outstanding at 4/16/26120,921,351

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
20254.8874.8
20244.80213.3
20234.72393.3
20224.64124.4
20214.4980.5

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware.

BUSINESS: Classified by the SEC under Standard Industrial Classification 2842, Specialty Cleaning, Polishing and Sanitation Preparations. Large accelerated filer. Principal executive office: The Clorox Company, 1221 Broadway, Oakland, CA 94612-1888. Fiscal year ends June 30. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)6/30/256/30/246/30/23
Revenues7,1047,0937,389
Cost of revenues3,8914,0454,481
Gross profit3,2133,0482,908
Research and development121126138
Selling, general and administrative1,1241,1671,183
Depreciation and amortization219235236
Interest expense889090
Income before income taxes1,078398238
Income taxes25410677
Net income810280149
Earned per share, diluted ($)6.522.251.20
Dividends per share ($)4.884.804.72

CONSOLIDATED BALANCE SHEET

($ millions)6/30/256/30/24
Cash and equivalents167202
Receivables, net821695
Inventories523637
Total current assets1,6081,622
Property, plant and equipment, net1,2671,315
Goodwill1,2291,228
Total assets5,5615,751
Total current liabilities1,9191,574
Long-term debt2,4842,481
Total liabilities5,0795,259
Stockholders' equity321328
Total liabilities and equity5,5615,751

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
6/30/257,104–81011.46.524.889812207615,5615,0792,488321252.37.75
6/30/247,093–2803.92.254.806952124835,7515,2592,48532885.47.58
6/30/237,389–1492.01.204.721,1582289305,9455,5572,52722067.711.49
6/30/227,107–4626.53.734.647862515356,1585,4292,71155683.14.88
6/30/217,341–7109.75.584.491,2763319456,3345,7422,784411172.76.77
6/30/206,721–93914.07.364.291,5462541,2926,2135,3052,780908103.43.06
6/30/196,214–82013.26.323.949922067865,1164,5572,683559146.74.80
6/30/186,124–82313.46.263.609761947825,0604,3342,483726113.43.42
6/30/175,973–70111.75.333.248652316344,5734,0312,195542129.34.05
6/30/165,761–64811.24.923.117781726064,5104,2132,312297218.27.78

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

CLOROX CO /DE/
CIK 21076 · EIN 31-0595760

PRINCIPAL OFFICE:

The Clorox Company, 1221 Broadway, Oakland, CA 94612-1888
Tel.: 5102717000

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

2842 · Specialty Cleaning, Polishing and Sanitation Preparations

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 6/30/26, filed 7 August 2026

FORMER NAMES:

CLOROX CO /DE/

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

10/7/26DEF 14Aperiod 11/18/26
8/7/2610-Kperiod 6/30/26
8/3/268-Kperiod 8/3/26
6/17/268-Kperiod 6/14/26
5/28/268-Kperiod 5/26/26
5/11/268-Kperiod 5/6/26
4/30/2610-Qperiod 3/31/26
4/30/268-Kperiod 4/30/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 8/8/25) · 10-K FY2024 (filed 8/8/24) · 10-K FY2023 (filed 8/10/23) · 10-K FY2022 (filed 8/10/22) · 10-K FY2021 (filed 8/10/21) · 10-K FY2020 (filed 8/13/20). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice